What are the medication options for managing drooling (sialorrhea) as a side effect of antipsychotic medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication Options for Antipsychotic-Induced Sialorrhea

Anticholinergic medications are the first-line pharmacological treatment for antipsychotic-induced sialorrhea, with glycopyrrolate being the preferred option due to its efficacy and favorable side effect profile. 1, 2

First-Line Treatment Options

Anticholinergic Medications

  1. Glycopyrrolate

    • Dosing: Start at 1 mg orally twice daily, titrate as needed 3
    • Benefits: Most favorable side effect profile among anticholinergics 2
    • FDA-approved: For chronic severe drooling (pediatric patients 3-16 years with neurological conditions) 4
    • Efficacy: Effective in alleviating clozapine-induced sialorrhea in multiple studies 3, 5
  2. Benztropine (Cogentin)

    • Dosing: 0.5-2 mg once or twice daily
    • Caution: Higher risk of cognitive side effects than glycopyrrolate
  3. Atropine

    • Dosing: 0.4-0.6 mg sublingually or 1-2 drops of 1% ophthalmic solution sublingually
    • Note: Effective but with more systemic anticholinergic effects 5
  4. Scopolamine (Hyoscine)

    • Dosing: Transdermal patch 1.5 mg every 72 hours
    • Note: Convenient application but may cause more confusion in elderly patients 2

Second-Line Treatment Options

Botulinum Toxin Injections

  • Indication: For patients with inadequate response or intolerance to anticholinergic medications 1
  • Dosing: IncobotulinumtoxinA (Xeomin) 100 Units into parotid and submandibular salivary glands in a 3:2 dose ratio
  • Benefits: Durable effects (weeks to months), minimal systemic side effects 1
  • Limitations: Requires specialized administration, temporary effect requiring repeated injections

Other Medication Options

  1. Alpha-2 Adrenergic Agonists

    • Clonidine: 0.1-0.2 mg twice daily
    • Mechanism: Reduces salivary flow by decreasing sympathetic tone
  2. Tricyclic Antidepressants

    • Amitriptyline: 10-25 mg at bedtime
    • Doxepin: 10-25 mg at bedtime
    • Note: Particularly useful for nocturnal sialorrhea due to sedating effects 5
  3. Dopamine Antagonists

    • Metoclopramide: 10 mg three times daily
    • Sulpiride: 50-100 mg twice daily
    • Note: Shown to be highly effective in recent network meta-analysis 5

Treatment Algorithm

  1. Initial Assessment:

    • Determine severity of sialorrhea (mild, moderate, severe)
    • Assess for risk factors: poor head control, impaired swallowing 2
    • Rule out other causes of increased salivation
  2. Non-pharmacological Approaches (try first or concurrently):

    • Increase frequency of swallowing with chewing gum 6
    • Consider antipsychotic dose adjustment if clinically appropriate
    • Split daily dose of antipsychotic if feasible 6
  3. Pharmacological Management:

    • Start with glycopyrrolate 1 mg twice daily
    • If ineffective after 1-2 weeks, increase dose gradually
    • If intolerable side effects develop, switch to alternative anticholinergic
    • For nocturnal sialorrhea, consider amitriptyline or doxepin at bedtime
  4. For Refractory Cases:

    • Consider botulinum toxin injections to salivary glands
    • Consider combination therapy (anticholinergic plus alpha-adrenergic agent)

Common Side Effects and Management

  • Anticholinergic Effects: Dry mouth, constipation, urinary retention, blurred vision, confusion

    • Management: Start with low doses, titrate slowly, ensure adequate hydration
    • Caution: Monitor closely in elderly patients and those with cognitive impairment
  • Specific to Glycopyrrolate 4:

    • Most common adverse reactions (≥30%): dry mouth, vomiting, constipation, flushing, nasal congestion
    • Monitoring: Assess for constipation within 4-5 days of initial dosing or after dose increase

Important Considerations

  • Avoid in patients with:

    • Narrow-angle glaucoma
    • Myasthenia gravis
    • Intestinal obstruction
    • Severe ulcerative colitis
    • Toxic megacolon
  • Drug Interactions 4:

    • Digoxin: Glycopyrrolate can increase digoxin serum levels
    • Amantadine: Effects of glycopyrrolate may be increased
    • Atenolol or metformin: Glycopyrrolate may increase their serum levels
  • Risk of Heat Prostration: Advise patients to avoid high ambient temperatures when taking anticholinergics 4

By following this structured approach to managing antipsychotic-induced sialorrhea, clinicians can effectively reduce this troublesome side effect while minimizing adverse effects, ultimately improving medication adherence and quality of life for patients.

References

Guideline

Sialorrhea Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.